O	0	7	Aglycon	Aglycon	NN	B-NP
O	8	10	of	of	IN	B-PP
O	11	22	rhizochalin	rhizochalin	NN	B-NP
O	23	27	from	from	IN	B-PP
O	28	31	the	the	DT	B-NP
O	32	44	Rhizochalina	Rhizochalina	NNP	I-NP
O	45	55	incrustata	incrustata	NN	I-NP
O	56	63	induces	induce	VBZ	B-VP
O	64	73	apoptosis	apoptosis	NN	B-NP
O	74	77	via	via	IN	B-PP
O	78	88	activation	activation	NN	B-NP
O	89	91	of	of	IN	B-PP
O	92	95	AMP	AMP	NN	B-NP
O	95	96	-	-	HYPH	B-NP
O	96	105	activated	activate	VBN	I-NP
O	106	113	protein	protein	NN	I-NP
O	114	120	kinase	kinase	NN	I-NP
O	121	123	in	in	IN	B-PP
B-Cell	124	126	HT	HT	NN	B-NP
I-Cell	126	127	-	-	HYPH	B-NP
I-Cell	127	129	29	29	CD	I-NP
I-Cell	130	135	colon	colon	NN	I-NP
I-Cell	136	142	cancer	cancer	NN	I-NP
I-Cell	143	148	cells	cell	NNS	I-NP
O	148	149	.	.	.	O

O	151	162	Rhizochalin	Rhizochalin	NN	B-NP
O	163	165	is	be	VBZ	B-VP
O	166	167	a	a	DT	B-NP
O	168	171	two	two	CD	I-NP
O	171	172	-	-	HYPH	I-NP
O	172	178	headed	head	VBN	I-NP
O	179	191	sphingolipid	sphingolipid	NN	I-NP
O	191	192	-	-	HYPH	O
O	192	196	like	like	JJ	B-NP
O	197	205	compound	compound	NN	I-NP
O	206	214	isolated	isolate	VBN	B-VP
O	215	219	from	from	IN	B-PP
O	220	223	the	the	DT	B-NP
O	224	230	sponge	sponge	NN	I-NP
O	231	243	Rhizochalina	Rhizochalina	NNP	I-NP
O	244	254	incrustata	incrustata	NNS	I-NP
O	254	255	.	.	.	O

O	256	258	It	It	PRP	B-NP
O	259	262	has	have	VBZ	B-VP
O	263	267	been	be	VBN	I-VP
O	268	276	reported	report	VBN	I-VP
O	277	281	that	that	IN	B-SBAR
O	282	292	rhizocalin	rhizocalin	NN	B-NP
O	293	296	and	and	CC	O
O	297	300	its	its	PRP$	B-NP
O	301	310	derivates	derivate	NNS	I-NP
O	311	315	have	have	VBP	B-VP
O	316	317	a	a	DT	B-NP
O	318	333	chemopreventive	chemopreventive	JJ	I-NP
O	334	337	and	and	CC	I-NP
O	338	354	chemotherapeutic	chemotherapeutic	JJ	I-NP
O	355	361	effect	effect	NN	I-NP
O	361	362	.	.	.	O

O	363	370	However	However	RB	B-ADVP
O	370	371	,	,	,	O
O	372	375	the	the	DT	B-NP
O	376	385	molecular	molecular	JJ	I-NP
O	386	395	mechanism	mechanism	NN	I-NP
O	396	398	of	of	IN	B-PP
O	399	404	these	these	DT	B-NP
O	405	412	effects	effect	NNS	I-NP
O	413	415	is	be	VBZ	B-VP
O	416	419	not	not	RB	I-VP
O	420	430	understood	understand	VBN	I-VP
O	430	431	.	.	.	O

O	432	436	Here	Here	RB	B-ADVP
O	436	437	,	,	,	O
O	438	440	we	we	PRP	B-NP
O	441	452	demonstrate	demonstrate	VBP	B-VP
O	453	457	that	that	IN	B-SBAR
O	458	465	aglycon	aglycon	NN	B-NP
O	466	468	of	of	IN	B-PP
O	469	480	rhizochalin	rhizochalin	NN	B-NP
O	481	482	(	(	(	O
O	482	488	AglRhz	AglRhz	NN	B-NP
O	488	489	)	)	)	O
O	490	494	from	from	IN	B-PP
O	495	498	the	the	DT	B-NP
O	499	511	Rhizochalina	Rhizochalina	NNP	I-NP
O	512	522	incrustata	incrustata	NN	I-NP
O	523	530	induces	induce	VBZ	B-VP
O	531	534	AMP	AMP	NN	B-NP
O	534	535	-	-	HYPH	O
O	535	544	activated	activate	VBN	B-NP
O	545	552	protein	protein	NN	I-NP
O	553	559	kinase	kinase	NN	I-NP
O	560	561	(	(	(	O
O	561	565	AMPK	AMPK	NN	B-NP
O	565	566	)	)	)	O
O	567	582	phosphorylation	phosphorylation	NN	B-NP
O	582	583	,	,	,	O
O	584	587	and	and	CC	O
O	588	595	thereby	thereby	RB	B-VP
O	596	604	inhibits	inhibit	VBZ	I-VP
O	605	614	mammalian	mammalian	JJ	B-NP
O	615	621	target	target	NN	I-NP
O	622	624	of	of	IN	B-PP
O	625	634	rapamycin	rapamycin	NN	B-NP
O	635	636	(	(	(	O
O	636	640	mTOR	mTOR	NN	B-NP
O	640	641	)	)	)	O
O	641	642	-	-	HYPH	O
O	642	647	p70S6	p70S6	NN	B-NP
O	648	654	kinase	kinase	NN	I-NP
O	654	655	-	-	HYPH	B-NP
O	655	668	extracellular	extracellular	JJ	I-NP
O	669	675	signal	signal	NN	I-NP
O	675	676	-	-	HYPH	B-NP
O	676	685	regulated	regulate	VBN	I-NP
O	686	692	kinase	kinase	NN	I-NP
O	693	694	(	(	(	O
O	694	697	ERK	ERK	NN	B-NP
O	697	698	)	)	)	O
O	699	708	signaling	signaling	NN	B-NP
O	709	712	and	and	CC	I-NP
O	713	722	activator	activator	NN	I-NP
O	723	730	protein	protein	NN	I-NP
O	731	732	1	1	CD	I-NP
O	733	734	(	(	(	O
O	734	736	AP	AP	NN	B-NP
O	736	737	-	-	HYPH	O
O	737	738	1	1	CD	O
O	738	739	)	)	)	O
O	740	748	activity	activity	NN	B-NP
O	749	752	via	via	IN	B-PP
O	753	768	phosphorylation	phosphorylation	NN	B-NP
O	769	771	of	of	IN	B-PP
O	772	778	Raptor	Raptor	NN	B-NP
O	779	781	in	in	IN	B-PP
B-Cell	782	784	HT	HT	NN	B-NP
I-Cell	784	785	-	-	HYPH	B-NP
I-Cell	785	787	29	29	CD	I-NP
I-Cell	788	793	cells	cell	NNS	I-NP
O	793	794	.	.	.	O

O	795	797	In	In	IN	B-PP
O	798	806	addition	addition	NN	B-NP
O	806	807	,	,	,	O
O	808	814	AglRhz	AglRhz	NNP	B-NP
O	815	822	induced	induce	VBD	B-VP
O	823	833	activation	activation	NN	B-NP
O	834	836	of	of	IN	B-PP
O	837	844	caspase	caspase	NN	B-NP
O	844	845	-	-	HYPH	B-NP
O	845	846	3	3	CD	I-NP
O	847	850	and	and	CC	O
O	851	855	poly	poly	NN	B-NP
O	855	856	(	(	(	O
O	856	859	ADP	ADP	NN	B-NP
O	859	860	-	-	HYPH	B-NP
O	860	866	ribose	ribose	NN	I-NP
O	866	867	)	)	)	O
O	868	878	polymerase	polymerase	NN	B-NP
O	879	880	(	(	(	O
O	880	884	PARP	PARP	NN	B-NP
O	884	885	)	)	)	O
O	885	886	,	,	,	O
O	887	890	and	and	CC	O
O	891	894	DNA	DNA	NN	B-NP
O	895	908	fragmentation	fragmentation	NN	I-NP
O	909	911	in	in	IN	B-PP
B-Cell	912	914	HT	HT	NN	B-NP
I-Cell	914	915	-	-	HYPH	B-NP
I-Cell	915	917	29	29	CD	I-NP
I-Cell	918	923	cells	cell	NNS	I-NP
O	923	924	,	,	,	O
O	925	930	leads	lead	VBZ	B-VP
O	931	933	to	to	TO	B-PP
O	934	943	induction	induction	NN	B-NP
O	944	946	of	of	IN	B-PP
O	947	956	apoptosis	apoptosis	NN	B-NP
O	957	959	as	as	RB	B-CONJP
O	960	964	well	well	RB	I-CONJP
O	965	967	as	as	IN	I-CONJP
O	968	979	suppression	suppression	NN	B-NP
O	980	982	of	of	IN	B-PP
O	983	997	tumorigenicity	tumorigenicity	NN	B-NP
O	998	1000	of	of	IN	B-PP
B-Cell	1001	1003	HT	HT	NN	B-NP
I-Cell	1003	1004	-	-	HYPH	B-NP
I-Cell	1004	1006	29	29	CD	I-NP
I-Cell	1007	1012	cells	cell	NNS	I-NP
O	1012	1013	.	.	.	O

O	1014	1021	Notably	Notably	RB	B-ADVP
O	1021	1022	,	,	,	O
O	1023	1029	AglRhz	AglRhz	NN	B-NP
O	1030	1038	inhibits	inhibit	VBZ	B-VP
O	1039	1046	insulin	insulin	NN	B-NP
O	1046	1047	-	-	HYPH	B-NP
O	1047	1051	like	like	JJ	I-NP
O	1052	1058	growth	growth	NN	I-NP
O	1059	1065	factor	factor	NN	I-NP
O	1066	1067	(	(	(	O
O	1067	1070	IGF	IGF	NN	B-NP
O	1070	1071	)	)	)	O
O	1071	1072	-	-	HYPH	B-NP
O	1072	1073	1	1	CD	I-NP
O	1073	1074	-	-	HYPH	I-NP
O	1074	1081	induced	induce	VBN	I-NP
O	1082	1084	AP	AP	NN	I-NP
O	1084	1085	-	-	HYPH	B-NP
O	1085	1086	1	1	CD	I-NP
O	1087	1095	activity	activity	NN	I-NP
O	1096	1099	and	and	CC	O
B-Cell	1100	1104	cell	cell	NN	B-NP
O	1105	1119	transformation	transformation	NN	I-NP
O	1120	1122	in	in	IN	B-PP
B-Cell	1123	1126	JB6	JB6	NN	B-NP
I-Cell	1127	1131	Cl41	Cl41	NN	I-NP
I-Cell	1132	1137	cells	cell	NNS	I-NP
O	1137	1138	.	.	.	O

O	1139	1146	Overall	Overall	RB	B-ADVP
O	1146	1147	,	,	,	O
O	1148	1151	our	our	PRP$	B-NP
O	1152	1160	findings	finding	NNS	I-NP
O	1161	1169	identify	identify	VBP	B-VP
O	1170	1174	AMPK	AMPK	NN	B-NP
O	1175	1177	as	as	IN	B-PP
O	1178	1180	an	an	DT	B-NP
O	1181	1190	important	important	JJ	I-NP
O	1191	1197	target	target	NN	I-NP
O	1198	1205	protein	protein	NN	I-NP
O	1206	1209	for	for	IN	B-PP
O	1210	1219	mediating	mediate	VBG	B-VP
O	1220	1223	the	the	DT	B-NP
O	1224	1228	anti	anti	AFX	I-NP
O	1228	1229	-	-	HYPH	I-NP
B-Cancer	1229	1234	tumor	tumor	NN	I-NP
O	1235	1245	properties	property	NNS	I-NP
O	1246	1248	of	of	IN	B-PP
O	1249	1255	AglRhz	AglRhz	NN	B-NP
O	1256	1258	in	in	IN	B-PP
B-Cell	1259	1261	HT	HT	NN	B-NP
I-Cell	1261	1262	-	-	HYPH	B-NP
I-Cell	1262	1264	29	29	CD	I-NP
I-Cell	1265	1270	colon	colon	NN	I-NP
I-Cell	1271	1277	cancer	cancer	NN	I-NP
I-Cell	1278	1283	cells	cell	NNS	I-NP
O	1284	1287	and	and	CC	O
O	1288	1292	have	have	VBP	B-VP
O	1293	1302	important	important	JJ	B-NP
O	1303	1314	implication	implication	NN	I-NP
O	1315	1318	for	for	IN	B-PP
O	1319	1326	sponges	sponge	NNS	B-NP
O	1326	1327	,	,	,	O
O	1328	1331	the	the	DT	B-NP
O	1332	1336	most	most	RBS	I-NP
O	1337	1346	important	important	JJ	I-NP
O	1347	1353	marine	marine	JJ	I-NP
O	1354	1360	source	source	NN	I-NP
O	1360	1361	,	,	,	O
O	1362	1364	in	in	IN	B-PP
B-Cancer	1365	1370	colon	colon	NN	B-NP
I-Cancer	1371	1377	cancer	cancer	NN	I-NP
O	1377	1378	.	.	.	O

